{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:14:44Z","timestamp":1790201684693,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging Clinics of North America"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.mric.2024.01.001","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T20:15:37Z","timestamp":1707768937000},"page":"363-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multiple Sclerosis"],"prefix":"10.1016","volume":"32","author":[{"given":"Phuong","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torge","family":"Rempe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Forghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.mric.2024.01.001_bib1","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.mric.2024.01.001_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncl.2017.08.002","article-title":"Multiple sclerosis: mechanisms of disease and strategies for myelin and axonal repair","volume":"36","author":"Lemus","year":"2018","journal-title":"Neurol Clin"},{"issue":"9","key":"10.1016\/j.mric.2024.01.001_bib3","doi-asserted-by":"crossref","first-page":"e00362","DOI":"10.1002\/brb3.362","article-title":"An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis","volume":"5","author":"Garg","year":"2015","journal-title":"Brain Behav"},{"issue":"6","key":"10.1016\/j.mric.2024.01.001_bib4","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/WCO.0000000000000622","article-title":"Multiple sclerosis: clinical aspects","volume":"31","author":"Oh","year":"2018","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"10.1016\/j.mric.2024.01.001_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mric.2024.01.001_bib6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.mric.2024.01.001_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41582-018-0082-z","article-title":"Treatment of multiple sclerosis - success from bench to bedside","volume":"15","author":"Tintore","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.mric.2024.01.001_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00011-018-1185-0","article-title":"A\u00a0comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future","volume":"68","author":"Gholamzad","year":"2019","journal-title":"Inflamm Res"},{"issue":"1","key":"10.1016\/j.mric.2024.01.001_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.mric.2024.01.001_bib10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.mric.2024.01.001_bib11","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/jamaneurol.2018.2160","article-title":"Application of the 2017 revised mcdonald criteria for multiple sclerosis to patients with a typical clinically isolated syndrome","volume":"75","author":"van der Vuurst de Vries","year":"2018","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1016\/j.mric.2024.01.001_bib12","first-page":"2684","article-title":"2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes","volume":"265","author":"Gaetani","year":"2018","journal-title":"J\u00a0Neurol"},{"issue":"1","key":"10.1016\/j.mric.2024.01.001_bib13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1212\/WNL.0000000000013016","article-title":"Performance of the 2017 and 2010 revised mcdonald criteria in predicting MS diagnosis after a clinically isolated syndrome: A MAGNIMS study","volume":"98","author":"Filippi","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.mric.2024.01.001_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.msard.2018.07.035","article-title":"Establishing the diagnosis of multiple sclerosis in Croatian patients with clinically isolated syndrome: 2010 versus 2017 McDonald criteria","volume":"25","author":"Habek","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"11","key":"10.1016\/j.mric.2024.01.001_bib15","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1177\/1352458518790702","article-title":"Application of the 2017 McDonald diagnostic criteria for multiple sclerosis in Korean patients with clinically isolated syndrome","volume":"25","author":"Hyun","year":"2019","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.mric.2024.01.001_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/ene.13853","article-title":"Diagnostic value of the 2017 McDonald criteria in patients with a first demyelinating event suggestive of relapsing-remitting multiple sclerosis","volume":"26","author":"Lee","year":"2019","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.mric.2024.01.001_bib17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","article-title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","volume":"15","author":"Filippi","year":"2016","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.mric.2024.01.001_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1474-4422(17)30469-6","article-title":"Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study","volume":"17","author":"Filippi","year":"2018","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.mric.2024.01.001_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3174\/ajnr.A4539","article-title":"Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis","volume":"37","author":"Traboulsee","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"issue":"8","key":"10.1016\/j.mric.2024.01.001_bib20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"Wattjes","year":"2021","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.mric.2024.01.001_bib21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3174\/ajnr.A1514","article-title":"Normal findings on brain fluid-attenuated inversion recovery MR images at 3T","volume":"30","author":"Neema","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1016\/j.mric.2024.01.001_bib22","first-page":"150","article-title":"Are periventricular lesions specific for multiple sclerosis?","volume":"4","author":"Casini","year":"2013","journal-title":"J\u00a0Neurol Neurophysiol"},{"issue":"7","key":"10.1016\/j.mric.2024.01.001_bib23","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1177\/1352458516667565","article-title":"Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes","volume":"23","author":"Brownlee","year":"2017","journal-title":"Mult Scler"},{"issue":"8","key":"10.1016\/j.mric.2024.01.001_bib24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nrneurol.2010.93","article-title":"Cortical lesions in multiple sclerosis","volume":"6","author":"Calabrese","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"10.1016\/j.mric.2024.01.001_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","article-title":"Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions","volume":"50","author":"Peterson","year":"2001","journal-title":"Ann Neurol"},{"issue":"15","key":"10.1016\/j.mric.2024.01.001_bib26","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0b013e3181a0fee5","article-title":"Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study","volume":"72","author":"Calabrese","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mric.2024.01.001_bib27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ana.21906","article-title":"A\u00a03-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis","volume":"67","author":"Calabrese","year":"2010","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.mric.2024.01.001_bib28","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1148\/radiol.2019181719","article-title":"Longitudinal characterization of cortical lesion development and evolution in multiple sclerosis with 7.0-T MRI","volume":"291","author":"Treaba","year":"2019","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.mric.2024.01.001_bib29","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1177\/13524585211069167","article-title":"Cortical lesion hotspots and association of subpial lesions with disability in multiple sclerosis","volume":"28","author":"Beck","year":"2022","journal-title":"Mult Scler. Aug"},{"issue":"3","key":"10.1016\/j.mric.2024.01.001_bib30","first-page":"572","article-title":"Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology","volume":"26","author":"Geurts","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.mric.2024.01.001_bib31","doi-asserted-by":"crossref","first-page":"102847","DOI":"10.1016\/j.nicl.2021.102847","article-title":"Imaging cortical multiple sclerosis lesions with ultra-high field MRI","volume":"32","author":"Madsen","year":"2021","journal-title":"Neuroimage Clin"},{"issue":"7","key":"10.1016\/j.mric.2024.01.001_bib32","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3174\/ajnr.A6099","article-title":"Comparison of multiple sclerosis cortical lesion types detected by multicontrast 3T and 7T MRI","volume":"40","author":"Maranzano","year":"2019","journal-title":"AJNR Am J Neuroradiol"},{"issue":"Pt 5","key":"10.1016\/j.mric.2024.01.001_bib33","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/brain\/aww037","article-title":"Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study","volume":"139","author":"Kilsdonk","year":"2016","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.mric.2024.01.001_bib34","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1093\/brain\/awaa233","article-title":"Histopathology-validated recommendations for cortical lesion imaging in multiple sclerosis","volume":"143","author":"Bouman","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.mric.2024.01.001_bib35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1148\/radiol.2361040450","article-title":"Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging","volume":"236","author":"Geurts","year":"2005","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.mric.2024.01.001_bib36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1212\/WNL.0b013e31824528a0","article-title":"Postmortem verification of MS cortical lesion detection with 3D DIR","volume":"78","author":"Seewann","year":"2012","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.mric.2024.01.001_bib37","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMcp053247","article-title":"Clinical practice. Optic neuritis","volume":"354","author":"Balcer","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mric.2024.01.001_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2014","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.mric.2024.01.001_bib39","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","author":"Group","year":"2008","journal-title":"Arch Neurol"},{"issue":"Pt 7","key":"10.1016\/j.mric.2024.01.001_bib40","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/brain\/awv105","article-title":"Defining high, medium and low impact prognostic factors for developing multiple sclerosis","volume":"138","author":"Tintore","year":"2015","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.mric.2024.01.001_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/19714009221124308","article-title":"MRI pattern in acute optic neuritis: Comparing multiple sclerosis, NMO and MOGAD","volume":"36","author":"Darakdjian","year":"2023","journal-title":"NeuroRadiol J"},{"issue":"1\u20132","key":"10.1016\/j.mric.2024.01.001_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2015.05.013","article-title":"Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis","volume":"355","author":"Mealy","year":"2015","journal-title":"J\u00a0Neurol Sci"},{"issue":"12","key":"10.1016\/j.mric.2024.01.001_bib43","doi-asserted-by":"crossref","first-page":"e1130","DOI":"10.1212\/WNL.0000000000006207","article-title":"Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis","volume":"91","author":"Brownlee","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mric.2024.01.001_bib44","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1212\/WNL.0000000000201465","article-title":"Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging","volume":"100","author":"Cortese","year":"2023","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.mric.2024.01.001_bib45","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/1971400918763577","article-title":"Multiple sclerosis: high prevalence of the 'central vein' sign in white matter lesions on susceptibility-weighted images","volume":"31","author":"Sparacia","year":"2018","journal-title":"NeuroRadiol J"},{"issue":"9","key":"10.1016\/j.mric.2024.01.001_bib46","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/RLI.0b013e3181b4c144","article-title":"A\u00a0comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions","volume":"44","author":"Tallantyre","year":"2009","journal-title":"Invest Radiol"},{"issue":"7","key":"10.1016\/j.mric.2024.01.001_bib47","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1212\/WNL.0b013e3182648bc8","article-title":"Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis","volume":"79","author":"Sinnecker","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mric.2024.01.001_bib48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.25146","article-title":"Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies","volume":"83","author":"Maggi","year":"2018","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.mric.2024.01.001_bib49","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001120","article-title":"Central vein sign profile of newly developing lesions in multiple sclerosis: a 3-year longitudinal study","volume":"9","author":"Al-Louzi","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"10.1016\/j.mric.2024.01.001_bib50","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3174\/ajnr.A1434","article-title":"First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T","volume":"30","author":"Kollia","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1016\/j.mric.2024.01.001_bib51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/acn3.273","article-title":"\"Central vessel sign\" on 3T FLAIR\u2217 MRI for the differentiation of multiple sclerosis from migraine","volume":"3","author":"Solomon","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"issue":"10","key":"10.1016\/j.mric.2024.01.001_bib52","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/14737175.2022.2143265","article-title":"What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?","volume":"22","author":"Martire","year":"2022","journal-title":"Expert Rev Neurother"},{"issue":"7","key":"10.1016\/j.mric.2024.01.001_bib53","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1177\/1352458520943785","article-title":"The central vein sign in multiple sclerosis patients with vascular comorbidities","volume":"27","author":"Guisset","year":"2021","journal-title":"Mult Scler"},{"issue":"12","key":"10.1016\/j.mric.2024.01.001_bib54","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrneurol.2016.166","article-title":"The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative","volume":"12","author":"Sati","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.mric.2024.01.001_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00234-021-02768-x","article-title":"Rim lesions are demonstrated in early relapsing-remitting multiple sclerosis using 3 T-based susceptibility-weighted imaging in a multi-institutional setting","volume":"64","author":"Ng Kee Kwong","year":"2022","journal-title":"Neuroradiology"},{"issue":"8","key":"10.1016\/j.mric.2024.01.001_bib56","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1177\/13524585231169466","article-title":"Paramagnetic rim lesions are associated with greater incidence of relapse and worse cognitive recovery following relapse","volume":"29","author":"Reeves","year":"2023","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.mric.2024.01.001_bib57","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/jmri.28847","article-title":"Evaluation of the Blood-Brain Barrier, Demyelination, and Neurodegeneration in Paramagnetic Rim Lesions in Multiple Sclerosis on 7 Tesla MRI","volume":"59","author":"Choi","year":"2024","journal-title":"J Magn Reson Imaging"},{"issue":"8","key":"10.1016\/j.mric.2024.01.001_bib58","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3174\/ajnr.A4726","article-title":"Lesion heterogeneity on high-field susceptibility MRI is associated with multiple sclerosis severity","volume":"37","author":"Harrison","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"issue":"13","key":"10.1016\/j.mric.2024.01.001_bib59","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1177\/13524585221102921","article-title":"Paramagnetic rim lesions are associated with pathogenic CSF profiles and worse clinical status in multiple sclerosis: A retrospective cross-sectional study","volume":"28","author":"Hemond","year":"2022","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.mric.2024.01.001_bib60","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/ana.26727","article-title":"Early magnetic resonance imaging features of new paramagnetic rim lesions in multiple sclerosis","volume":"94","author":"Clark","year":"2023","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.mric.2024.01.001_bib61","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2214\/AJR.21.26777","article-title":"Paramagnetic rim lesions in multiple sclerosis: comparison of visualization at 1.5-T and 3-T MRI","volume":"219","author":"Hemond","year":"2022","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.mric.2024.01.001_bib62","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/ana.25877","article-title":"Paramagnetic rim lesions are specific to multiple sclerosis: an international multicenter 3t mri study","volume":"88","author":"Maggi","year":"2020","journal-title":"Ann Neurol"},{"issue":"14","key":"10.1016\/j.mric.2024.01.001_bib63","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1177\/13524585221118677","article-title":"Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis","volume":"28","author":"Meaton","year":"2022","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.mric.2024.01.001_bib64","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp.64.3.353","article-title":"Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination","volume":"64","author":"O'Riordan","year":"1998","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.mric.2024.01.001_bib65","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1352458517697830","article-title":"Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor","volume":"24","author":"Arrambide","year":"2018","journal-title":"Mult Scler"},{"issue":"5","key":"10.1016\/j.mric.2024.01.001_bib66","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/1352458516663034","article-title":"Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome","volume":"23","author":"Brownlee","year":"2017","journal-title":"Mult Scler"},{"issue":"8","key":"10.1016\/j.mric.2024.01.001_bib67","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/brain\/awz156","article-title":"Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis","volume":"142","author":"Brownlee","year":"2019","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.mric.2024.01.001_bib68","article-title":"Recurrence and prognostic value of asymptomatic spinal cord lesions in multiple sclerosis","volume":"10","author":"Ostini","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"12","key":"10.1016\/j.mric.2024.01.001_bib69","first-page":"3031","article-title":"Spinal cord lesions are frequently asymptomatic in relapsing-remitting multiple sclerosis: a retrospective MRI survey","volume":"266","author":"Granella","year":"2019","journal-title":"J\u00a0Neurol"},{"issue":"6","key":"10.1016\/j.mric.2024.01.001_bib70","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/1352458515599246","article-title":"Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis","volume":"22","author":"Zecca","year":"2016","journal-title":"Mult Scler"},{"issue":"10","key":"10.1016\/j.mric.2024.01.001_bib71","first-page":"4995","article-title":"The added value of spinal cord lesions to disability accrual in multiple sclerosis","volume":"270","author":"Ruggieri","year":"2023","journal-title":"J\u00a0Neurol"},{"issue":"4","key":"10.1016\/j.mric.2024.01.001_bib72","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/1352458517736147","article-title":"Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis","volume":"24","author":"Dekker","year":"2018","journal-title":"Mult Scler"},{"issue":"12","key":"10.1016\/j.mric.2024.01.001_bib73","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3174\/ajnr.A5773","article-title":"Gadolinium and multiple sclerosis: vessels, barriers of the brain, and glymphatics","volume":"39","author":"Saade","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"issue":"Pt 5","key":"10.1016\/j.mric.2024.01.001_bib74","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/brain\/116.5.1077","article-title":"Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis","volume":"116","author":"Miller","year":"1993","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.mric.2024.01.001_bib75","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1148\/radiol.2019181568","article-title":"Accuracy of unenhanced MRI in the detection of new brain lesions in multiple sclerosis","volume":"291","author":"Eichinger","year":"2019","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.mric.2024.01.001_bib76","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3174\/ajnr.A5828","article-title":"Do all patients with multiple sclerosis benefit from the use of contrast on serial follow-up mr imaging? a retrospective analysis","volume":"39","author":"Mattay","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"10.1016\/j.mric.2024.01.001_bib77","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/jmri.21973","article-title":"Risk factors for NSF: a literature review","volume":"30","author":"Prince","year":"2009","journal-title":"J\u00a0Magn Reson Imag"},{"issue":"4","key":"10.1016\/j.mric.2024.01.001_bib78","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/RMR.0000000000000095","article-title":"Adverse effects of gadolinium-based contrast agents: changes in practice patterns","volume":"25","author":"Forghani","year":"2016","journal-title":"Top Magn Reson Imag"},{"issue":"8","key":"10.1016\/j.mric.2024.01.001_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12081816","article-title":"Nephrogenic systemic fibrosis in patients with chronic kidney disease after the use of gadolinium-based contrast agents: a review for the cardiovascular imager","volume":"12","author":"Gallo-Bernal","year":"2022","journal-title":"Diagnostics"},{"issue":"7","key":"10.1016\/j.mric.2024.01.001_bib80","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1474-4422(17)30158-8","article-title":"Gadolinium deposition in the brain: summary of evidence and recommendations","volume":"16","author":"Gulani","year":"2017","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.mric.2024.01.001_bib81","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1148\/radiol.13131669","article-title":"High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material","volume":"270","author":"Kanda","year":"2014","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.mric.2024.01.001_bib82","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/1352458520911174","article-title":"Gadolinium should always be used to assess disease activity in MS - Yes","volume":"26","author":"Granziera","year":"2020","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.mric.2024.01.001_bib83","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2214\/AJR.21.26999","article-title":"Routine gadolinium use for MRI follow-up of multiple sclerosis: point-the role of leptomeningeal enhancement","volume":"219","author":"Okar","year":"2022","journal-title":"AJR Am J Roentgenol"}],"container-title":["Magnetic Resonance Imaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968924000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968924000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T05:07:45Z","timestamp":1729141665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064968924000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1064968924000011"],"URL":"https:\/\/doi.org\/10.1016\/j.mric.2024.01.001","relation":{},"ISSN":["1064-9689"],"issn-type":[{"value":"1064-9689","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mric.2024.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}